Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Abrocitinib may effectively treat stubborn alopecia universalis.

MitoQ may help treat hair loss by boosting hair growth pathways.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Deleting MPZL3 increases skin oil production and reduces body fat.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Bazi Bushen capsules reduce skin aging and damage from UV rays.

Semaglutide may worsen eating disorders in vulnerable individuals.

CTP-543 is generally safe for treating alopecia areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib treatment for hair loss may worsen acne.

Bortezomib chemotherapy can cause temporary skin rashes.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Cetirizine lotion can effectively treat female pattern hair loss.

New cytokine-targeted therapies show promise for treating alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.